PHI recognized at optical exhibition
San Francisco, February 1, 2018
SPIE Photonics West is by far the largest optical conference in the world, with over 20 000 attendees and 1 300 exhibitors. Daily during the three-day exhibition, a new issue of the exhibition magazine Photonics West Show Daily is handed out. In Thursday’s issue both PHI and the core technology quantitative phase imaging (QPI) were featured in the multiple page article “Killer potential: time to raise the profile of QPI”. The article is found on page 7 at optics.org/showdaily/showdaily1803.pdf#page=7.
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.